ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,333 | -19.2% | 212,111 | +0.8% | 0.00% | – |
| Q2 2023 | $787,383 | +8.4% | 210,530 | -2.9% | 0.00% | – |
| Q1 2023 | $726,193 | +2.1% | 216,774 | +46.5% | 0.00% | – |
| Q4 2022 | $711,538 | +7.2% | 147,929 | +26.8% | 0.00% | – |
| Q3 2022 | $664,000 | -22.8% | 116,640 | -3.7% | 0.00% | – |
| Q2 2022 | $860,000 | +13.5% | 121,132 | +15.3% | 0.00% | – |
| Q1 2022 | $758,000 | +155.2% | 105,018 | +215.4% | 0.00% | – |
| Q4 2021 | $297,000 | -97.3% | 33,293 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $11,134,000 | +2279.1% | 317,579 | +1356.9% | 0.00% | – |
| Q2 2021 | $468,000 | -11.2% | 21,798 | +155.2% | 0.00% | – |
| Q1 2021 | $527,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |